Adenosine is a potent anti-inflammatory agent that modulates the function of cells involved in the inflam
During conditions associated with metabolic stress, such as ischemia, tissue injury, and inflammation, adenosine can be formed and released into the extracellular space as a result of a rapid degradation of intracellular ATP (10, 24, 30, 44) . At these concentrations, adenosine modulates functional responses of inflammatory cells, including monocytes (31) . By the occupancy of A 2 receptors, adenosine inhibits the production of tumor necrosis factor alpha and interleukin 12 (IL-12) (3, 17, 29, 37) , whereas secretion of IL-10, a protective cytokine that suppresses release of IL-12 and tumor necrosis factor alpha, was found to be enhanced (16, 25) . Besides diminishing cytokine production, adenosine exerts other anti-inflammatory effects, including inhibition of phagocytosis and C2 production (11, 23) . Testing the ability of adenosine to inhibit phagocytosis by monocytes and macrophages, Eppell et al. (11) found that while adenosine had no effect on phagocytosis of freshly isolated monocytes, it acts as a powerful inhibitor in macrophages. According to their data, differentiation of monocytes to macrophages is accompanied by a dramatic increase of A 2 receptors, implying that inhibition of the phagocytic activity is regulated by A 2 receptors.
Another important biological response associated with inflammation is the release of reactive oxygen intermediates (ROI) by phagocytes. ROI, including hydrogen peroxide (H 2 O 2 ), hydroxyl radical (OH Ϫ ), and hypochlorous acid (HOCl), are derived from O 2 Ϫ , which is produced in the so-called respiratory burst via an NADPH oxidase. By generating these toxic oxidants, phagocytes kill and degrade invading microorganisms. However, an uncontrolled production of ROI in various inflammatory conditions may result in pathological tissue injury (2, 19) . Whereas much attention has been paid to the inhibitory action of adenosine on the oxidative burst in neutrophils (6, 7, 9, 14, 42) , little is known about its action in monocytes. Therefore, we tested the ability of adenosine to modulate lipopolysaccharide (LPS)-induced ROI production in human monocytes and studied the role of adenosine receptors involved in this process. Furthermore, we investigated whether differentiation of monocytes to macrophages is accompanied by changes in the inhibitory action of adenosine on ROI production and whether differentiation has any impact on the mRNA expression of the four adenosine receptor subtypes.
were expressed as the ratio of dye fluorescence at 340 nm to that at 380 nm. Calcium measurements were performed on fields containing 45 to 70 cell bodies.
Luminol-amplified chemiluminescence assay. Chemiluminescence assays were performed at 37°C using a MicroLumat 96P luminometer (Berthold, Bad Wildbad, Germany). Monocytes (1.6 ϫ 10 6 /ml) were suspended in RPMI 1640 (without phenol red) supplemented with 1% fetal calf serum and 5 mM HEPES (Seromed Biochrom KG, Berlin, Germany). The cells were allowed to equilibrate at 37°C and 5% CO 2 for 30 min in white polystyrene 96 microtiter plates (Wallac, Turku, Finland) in the presence of 140 M luminol in a final volume of 250 l. Then the plates were transferred to the luminometer and background readings were recorded. After 30 min, the agonist, the antagonist, or, with a latency of 5 min, both the antagonist and then the agonist were added to the cells and incubation continued for an additional 30 min before LPS (100 ng/ml) was added. The readings continued for a further 120 min.
All data are based on the calculation of the area under the curve by using the Winglow 1.02 program (Berthold). Percentage inhibition was calculated in relation to the control. Luminol-dependent chemiluminescence (LDCL) is given in terms of relative light units per second.
Semiquantitative reverse transcription-PCR. Total RNA was isolated from 6 ϫ 10 6 cells by using an RNeasy mini kit (Qiagen, Chatsworth, Calif.) according to the manufacturer's instructions. cDNA was prepared by annealing RNA with oligo(dT) 20 for 10 min at 70°C and reverse transcription using SuperScript II reverse transcriptase (Life Technologies, Gaithersburg, Md.) at 37°C for 60 min, followed by an inactivation phase of 4 min at 94°C.
An aliquot of each reverse transcription sample was added to the reaction mixture containing 1.5 mM MgCl 2 , 200 M deoxynucleoside triphosphate, and 1 M concentrations of both the sense and antisense primers and 30 U of Taq DNA polymerase (Life Technologies)/ml.
The primers used in the PCR were as follows: for the A 1 receptor cDNA, sense primer 5Ј-CAC CTT CTG CTT CAT CGT GTC and antisense primer 5Ј-AGC CAA ACA TAG GGG TCA GTC; for the A 2A receptor cDNA, sense primer 5Ј-ACC TGC AGA AGC TCA CCA AC and antisense primer 5Ј-TCT GCT TCA GCT GTC GTC GC; for the A 2B receptor cDNA, sense primer 5Ј-GCC ATG CTG CTG GAG ACA CAG and antisense primer 5Ј-CTG GAG GGT GGT CCT CGA GTG; for the A 3 receptor cDNA, (4), sense primer 5Ј-GCT TAT CTT TAC CCA CGC CTC C and antisense primer 5Ј-CCG TCT TGA ACT CCC GTC CAT A; and for the GAPDH cDNA, sense primer 5Ј-AAC AGC GAC ACC CAC TCC TC and antisense primer 5Ј-GGA GGG GAG ATT CAG TGT GGT. All primer pairs used were intron spanning.
Reactions were performed in a Crocodile III DNA thermal cycler (Oncor Appligene, Heidelberg, Germany) under the following conditions: an initial denaturation step for 5 min at 95°C followed by cycles of 60 s at 95°C, 60 s at 65°C (A 1 ), 62°C (A 2A ), 68°C (A 2B and A 3 ), or 60°C (GAPDH), and 90 s at 72°C, with a prolongation of 2 s per cycle. The final extension phase was 5 min at 72°C. The numbers of cycles were 35 for A 1 ; 30 for A 2A , A 2B , and A 3 ; and 20 for GAPDH. The PCR products were separated by electrophoresis on 1.8% agarose gels (FMC Bioproducts, Rockland, Mass.) containing 1 g of ethidium bromide/ml and visualized under UV light. The 100-bp ladder (Life Technologies) served as a molecular weight standard. The amounts of GAPDH PCR product were used as a reference.
Statistics. Each experiment was performed in duplicate. The WinGlow 1.02 program (Berthold) was used for data analysis. Data are presented as means Ϯ standard errors of the means (SEM) of three independent experiments. Multiple comparisons with a control value were performed by one-way analysis of variance followed by Bonferroni's t test. All other comparisons were made by paired Student's t test. A probability level of 0.05 or less was considered to be statistically significant. The concentration-response curves were confirmed by a nonlinear regression. The 50% inhibitory concentrations (IC 50 s) were calculated from the concentration-response curves.
RESULTS
Adenosine inhibits LPS-induced ROI production in freshly isolated and cultured human monocytes. Treatment of freshly isolated monocytes with LPS (100 ng/ml) led to a rapid production of ROI (Fig. 1) . In the absence of LPS, no ROI were produced. When the monocytes were preincubated with adenosine (1, 10, 50, 100, and 200 M), LPS-triggered ROI production was suppressed in a concentration-dependent manner (IC 50 Ϸ 33.6 M) (Fig. 2) . The course of the concentration-response curve was similar when cultured monocytes were used (IC 50 Ϸ 8.5 M) (Fig. 2) . A cultivation time of 18 h was chosen because at later time points monocytes cease to produce ROI in response to LPS (27, 33, 43, 46) . At an adenosine concentration of 200 M, ROI production in freshly isolated and cultured monocytes was inhibited by 41.1% Ϯ 3.6% (n ϭ 3) and 44.3% Ϯ 4% (n ϭ 3), respectively.
Effect of adenosine deaminase, EHNA, and dipyridamole on LPS-induced and adenosine-mediated inhibition of ROI production. As adenosine inhibited ROI production in monocytes less efficiently (IC 50 in the micromolar range) than has been described for neutrophils (IC 50 in the micromolar range [9, 42] ), we measured ROI production in the presence of adenosine deaminase, which hydrolyzes adenosine to inosine, to exclude an effect of endogenous adenosine. As shown in Fig. 3A , the enzyme did not enhance ROI production induced by LPS, nor did it abolish the inhibitory action of adenosine. It even caused a slight decrease in ROI production in the absence or presence of adenosine.
We can exclude the possibility that the adenosine deaminase-mediated decrease was due to an accumulation of inosine, a degradation product of adenosine (Fig. 3B) , which recently has been suggested to suppress IL-12 production (18) . Despite the addition of adenosine deaminase to the cells, adenosine still exerted its effects. It is possible that adenosine deaminase is already present, as described previously (1, 12) , so that a further addition of the enzyme has no effect or that the net concentration of adenosine remains constant due to the concerted action of adenosine-degrading and -producing enzymes in activated cells. To elucidate the specific action of adenosine deaminase, LPS-stimulated monocytes were incubated with the adenosine deaminase inhibitor EHNA in the presence or absence of adenosine (Fig. 3A) . The presence of EHNA led to a decrease in the LPS-induced burst by 85% and the adenosine-mediated inhibition was further potentiated, resulting in a nearly complete blocking of the burst. These data show that adenosine deaminase is highly active in LPS-stimulated monocytes and that adenosine, when spared from degradation by adenosine deaminase, very effectively inhibits the burst.
To test whether cellular uptake of adenosine by monocytes influences the inhibitory effect on ROI production, the cells were treated with dipyridamole (0.1, 1, and 10 M) prior to the addition of adenosine (10, 100, and 200 M) and LPS (100 ng/ml). As shown in Fig. 3C , dipyridamole by itself inhibited the ROI production in a concentration-dependent manner. Addition of adenosine potentiated this inhibitory effect.
Analysis of adenosine receptor subtype mRNA expression in freshly isolated and cultured human monocytes and in macrophages. The inhibitory action of adenosine on the LPSinduced oxidative burst and the potentiation of this effect when the adenosine uptake is blocked imply the involvement of adenosine receptor subtypes. Before identifying the receptor(s) mediating the action, we determined which of the four receptor mRNAs were present in monocytes and whether they were regulated during cultivation. The expression of the A 2A and A 2B receptor mRNA was far less pronounced in freshly isolated than in cells cultured for 18 h (Fig. 4) . After 7 days in culture, A 2B receptor mRNA expression hardly changed whereas A 2A receptor mRNA was no longer detectable. The kinetics of the A 1 and A 3 receptor mRNA expression showed a slight increase after 7 days of culture.
Effect of adenosine receptor antagonists on the adenosineinduced inhibition of LPS-induced ROI production. Having shown that the mRNA of all receptors is present in freshly isolated monocytes and in monocytes cultured for 18 h, the role of the receptor(s) involved in the inhibitory action of adenosine on the LPS-induced oxidative burst was investigated. Cells were preincubated with receptor-selective antagonists for 5 min before adenosine was added. The antagonists, which were used at a concentration of 1 M, by themselves did not induce ROI production either in the presence or in the absence of LPS. To block A 1 , DPCPX was used (22) . It did not FIG. 1. Concentration-response curves showing the effect of adenosine on LPS-induced ROI production in freshly isolated monocytes. ROI production was determined by LDCL as described in Materials and Methods. Freshly isolated monocytes (1.6 ϫ 10 6 /ml) were incubated in the presence of adenosine for 30 min before LPS (100 ng/ml) was added. A representative recording of three different experiments is shown. RLU, relative light units.
FIG. 2. Concentration-response curves
showing the effect of adenosine on LPS-induced ROI production in freshly isolated and cultured monocytes. ROI production was determined by LDCL as described in Materials and Methods. Freshly isolated and cultured monocytes (1.6 ϫ 10 6 /ml) were incubated in the presence of adenosine for 30 min before LPS (100 ng/ml) was added. All data are expressed as percentages of the LPS (100 ng/ml)-induced ROI formation (100%). Each point represents the mean Ϯ SEM of three independent experiments.
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reverse the effect of adenosine, with the inhibition being 38% in freshly isolated and 46% in cultured monocytes (Fig. 5) . In the presence of XAC, which possesses high affinity at the A 2A receptors (1 nM) (22) but also exhibits nanomolar affinity for the other three receptors (20, 22, 28) , the adenosine-induced inhibition was prevented in freshly isolated monocytes. In cultured monocytes, XAC not only reversed the inhibitory action of adenosine but even stimulated ROI production. Similar to XAC, the A 3 antagonist MRS 1220, a xanthine derivative, which is highly selective for human A 3 receptor (21), but in the nanomolar range also blocks A 2A (32) , reversed the effect of adenosine in both cell populations. Effect of receptor agonists on LPS-induced ROI production. As XAC and MRS 1220 reversed the inhibitory action of adenosine, we tested whether CGS 21680, a nonselective A 2A and A 3 receptor agonist (22) , and IB-MECA, a nonselective A 1 and A 3 receptor agonist (22) , have similar effects as adenosine. In freshly isolated and cultured monocytes, CGS 21680 suppressed the production of ROI in a dose-dependent manner (Fig. 6A) . At a concentration of 50 M, inhibition of ROI production in cultured monocytes was more pronounced (68%) than in freshly isolated monocytes (39%) (Fig. 6A) .
To define the action of CGS 21680 more precisely, the cells were preincubated with the antagonists DPCPX, MRS 1220, and XAC before CGS 21680 and LPS were added. As shown in Fig. 6B , DPCPX had no effect, MRS 1220 slightly reduced the CGS 21680-induced inhibition, and XAC partly prevented the inhibition. Compared to CGS 21680, IB-MECA suppressed the LPSinduced ROI production more efficiently (Fig. 7A) . At a concentration of only 10 M, inhibitions in freshly isolated and cultured monocytes were found to be 45 and 67%, respectively. The inhibitory effect of IB-MECA could be prevented by XAC, whereas MRS 1220 partly reversed the inhibition and DPCPX had no effect (Fig. 7B) .
Calcium signaling in response to adenosine. Multiple intracellular signaling pathways can be induced by adenosine receptor stimulation. We tested how far modulation of Ca 2ϩ mobilization could be involved in the adenosine-mediated inhibition of the LPS-induced oxidative burst. As shown in Fig.  8A , incubation of monocytes with LPS (100 ng/ml) led to a minor gradual increase in [Ca 2ϩ ] i . The addition of adenosine, which by itself elicits a rapid rise in [Ca 2ϩ ] i , prior to stimulation with LPS had no effect on the LPS-induced change in [Ca 2ϩ ] i (Fig. 8B) , indicating that the inhibitory action of adenosine is unlikely to be mediated by changes in [Ca 2ϩ ] i .
DISCUSSION
Here we show that differentiation of monocytes to macrophages is accompanied by a change in the mRNA expression of the four adenosine receptor subtypes. Already at 18 h after cultivation, an increase of both A 2A and A 2B receptor mRNA can be seen. Prolonging the cultivation time up to 7 days, during which monocytes differentiate to macrophages, results in the disappearance of A 2A receptor mRNA expression. However, expression of A 2B receptor mRNA is still higher than in freshly isolated monocytes. Consistent with this latter finding, Eppell et al. showed by functional analysis that differentiation of monocytes to macrophages is associated with an increase in A 2 receptors (11), presumably the A 2B receptor.
When studying the involvement of the adenosine receptors in mediating the adenosine-induced inhibition of ROI production, relatively high concentrations (micromolar) of adenosine were needed to exert an effect. This is in line with data from other reports in which the inhibitory action of adenosine on ROI production and other biological answers in monocytes have been described (3, 4, 17, 26, 40) . According to our data, the IC 50 s may result from a rapid uptake and an extensive metabolism of adenosine.
We found that the blockade of adenosine uptake (by dipy -FIG. 4 . Adenosine receptor subtype mRNA expression in freshly isolated and cultured human monocytes. cDNAs of freshly isolated monocytes and monocytes cultured for 18 h and 7 days were prepared. Semiquantitative PCR was performed with specific primers for A 1 , A 2A , A 2B , and A 3 adenosine receptors and GAPDH. The amounts of GAPDH PCR products were used as a reference for semiquantitative analysis. As a negative control, water was used in the PCR. The 100-bp ladder was used as a DNA size marker. One representative experiment out of three is shown. FIG. 3 . Effect of adenosine deaminase, EHNA, inosine, and dipyridamole on LPS-induced and adenosine-mediated inhibition of ROI production. ROI production was determined by LDCL as described in Materials and Methods. (A) Freshly isolated monocytes (1.6 ϫ 10 6 /ml) were incubated either in the presence or absence of adenosine deaminase (0.25 U/ml) or EHNA (5 M) for 5 min prior to the addition of adenosine (100 M), and LPS (100 ng/ml) was added after 30 min. All data are expressed as percentages of the LPS (100 ng/ml)-induced ROI formation (100%). Data represent the means Ϯ SEM of two to three independent experiments. (B) Freshly isolated and cultured monocytes (1.6 ϫ 10 6 /ml) were incubated with different concentrations of inosine for 30 min prior to the addition of LPS (100 ng/ml). All data are expressed as percentages of the LPS (100 ng/ml)-induced ROI formation (100%). Each point represents the mean Ϯ SEM of three independent experiments. (C) Freshly isolated and cultured monocytes (1.6 ϫ 10 6 /ml) were incubated with 0, 0.1, 1, or 10 M dipyridamole for 5 min prior to the addition of different concentrations of adenosine, and LPS (100 ng/ml) was added after 30 min. All data are expressed as percentages of the LPS (100 ng/ml)-induced ROI formation (100%). Each point represents the mean Ϯ SEM of three independent experiments.
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on July 4, 2017 by guest http://iai.asm.org/ ridamole) and the inhibition of endogenous adenosine deaminase activity (by EHNA) both resulted in a decrease in LPSinduced ROI production even in the absence of exogenous adenosine, indicating that endogenous adenosine is produced in stimulated monocytes and that adenosine, if spared from uptake and degradation, exerts its inhibitory effects by acting at its receptors. To our surprise, the addition of adenosine deaminase to the cells in the absence or presence of adenosine did not result in an increase in ROI production. The fact that inhibition of adenosine deaminase by EHNA caused a drastic inhibition of the oxidative burst points to high adenosine deaminase activity so that further addition of adenosine deaminase may not affect the equilibrium between adenosine and adenosine deaminase in the cell culture. A 3 (monocytes) and A 2A and probably A 3 (neutrophils) have mainly been suggested to be the adenosine receptor subtypes that mediate the inhibitory action of adenosine on fMLP (formyl-Met-Leu-Phe)-induced respiratory burst in monocytes (4) and neutrophils (9, 14) . In line with these observations, our data indicate that the action of adenosine on LPS-induced ROI production depends on A 3 and probably also A 2A activation. This conclusion is based on the observation that the A 2A and A 3 antagonists XAC and MRS 1220 blocked the inhibitory action of adenosine while the A 1 antagonist DPCPX was without effect.
In humans, XAC has been described as A 2A selective (K i ϳ 1 nM) (22) , with the K i for A 3 being 92 nM (22) , and MRS 1220 has been described as A 3 selective (K i ϳ 0.65 nM) (21), with the K i for A 2A being 15 nM (32). It should be pointed out that at a concentration of 1 M, as used in this study, both antagonists can block both receptor subtypes. Lowering the concentration of XAC and MRS 1220 to 10 nM, a concentration at which MRS 1220 might bind only to A 3 and XAC only to A 2A did not prevent the inhibition induced by adenosine (100 M), IB-MECA (10 M), or CGS 21680 (50 M) (data not shown). This might be due to the fact that the concentration of the antagonists is 10,000 to 1,000 times lower than that of the agonists.
Irrespective of these limitations, IB-MECA, a nonselective A 1 and A 3 receptor agonist (22) , and CGS 21680, which shows some degree of selectivity for A 2A receptors (22) , were tested for their ability to block LPS-induced ROI production. Both agonists dose dependently inhibited ROI formation, with IB-MECA being more effective than CGS 21680. Similar to adenosine, IB-MECA and CGS 21680 exerted their effects only at concentrations in the micromolar range. The presence of adenosine deaminase had no influence on their inhibitory action (data not shown). As the enzyme did not prevent the inhibitory action of exogenous adenosine, it is possible that due to the endogenous enzyme activity the adenosine concentration is too low to be responsible for the low affinity of the agonist. However, despite its relatively low affinity to the adenosine receptor, IB-MECA induced a complete inhibition of LPS-induced ROI production while adenosine only partly prevented ROI production. It is most likely that adenosine, in contrast to IB-MECA, is metabolized by adenosine deaminase or that adenosine binds to several receptors whereas IB-MECA is more selective.
As IB-MECA is more efficient than CGS 21680 in inhibiting the LPS-induced respiratory burst, an involvement of A 3 seems more likely than that of A 2A . However, the fact that inhibition induced by CGS 21680 and IB-MECA were both prevented by XAC, only partly blocked by MRS 1220, but not prevented by DPCPX supports an involvement of A 2A and A 3 . The ability of XAC to prevent the effects of both CGS 21680 and IB-MECA FIG. 5 . Effects of adenosine and adenosine receptor antagonists on LPS-induced ROI production in freshly isolated and cultured monocytes. ROI production was determined by LDCL as described in Materials and Methods. Freshly isolated and cultured monocytes (1.6 ϫ 10 6 /ml) were preincubated with the respective adenosine antagonists for 5 min before adenosine was added. After 30 min of incubation, cells were stimulated with LPS (100 mg/ml). The antagonists used to block the adenosine receptor subtypes were DPCPX, XAC, and MRS 1220. All data are expressed as percentages of the LPS (100 ng/ml)-induced ROI production (100%). Data represent the means Ϯ SEM of three independent experiments. ‫,ء‬ P Ͻ 0.05 (significant difference compared to the LPS-induced ROI production); §, P Ͻ 0.05 (significant difference compared to the adenosineinduced inhibition of ROI production). 3 receptor agonist CGS 21680 on LPS-induced ROI production in freshly isolated and cultured monocytes. ROI production was determined by LDCL as described in Materials and Methods. Freshly isolated monocytes and cultured monocytes (1.6 ϫ 10 6 /ml) were incubated with CGS 21680 (1 to 50 M) for 30 min before addition of LPS (100 mg/ml). Data represent the means Ϯ SEM of three independent experiments. (B) Effect of adenosine antagonists on CGS 21680-mediated inhibition of LPS-induced ROI production. ROI production was determined by LDCL as described in Materials and Methods. Freshly isolated monocytes (1.6 ϫ 10 6 /ml) were incubated with 1 M concentrations of the antagonist DPCPX, XAC, or MRS 1220 for 5 min before CGS 21680 (50 M) was added. After 30 min of incubation, the cells were stimulated with LPS (100 mg/ml). All data are expressed as percentages of the LPS (100 ng/ml)-induced ROI production (100%). Each point represents the mean Ϯ SEM of three independent experiments.
FIG. 7. (A)
Concentration-response curves showing the effect of the A 1 and A 3 receptor agonist IB-MECA on LPS-induced ROI production in freshly isolated and cultured monocytes. ROI production was determined by LDCL as described in Materials and Methods. Freshly isolated monocytes and cultured monocytes (1.6 ϫ 10 6 /ml) were incubated with IB-MECA (1 to 50 M) for 30 min before addition of LPS (100 mg/ml). Each point represents the mean Ϯ SEM of three independent experiments. (B) Effect of adenosine antagonists on IB-MECA-mediated inhibition of LPS-induced ROI production. ROI production was determined by LDCL as described in Materials and Methods. Freshly isolated monocytes (1.6 ϫ 10 6 /ml) were incubated with a 1 M concentration of the antagonist DPCPX, XAC, or MRS 1220 for 5 min before IB-MECA (10 M) was added. After 30 min of incubation, the cells were stimulated with LPS (100 mg/ml). All data are expressed as percentages of the LPS (100 ng/ml)-induced ROI production (100%). Data represent the means Ϯ SEM of three independent experiments. ‫,ء‬ P Ͻ 0.05 (significant difference compared to the LPS-induced ROI production); §, P Ͻ 0.05 (significant difference compared to the IB-MECA-induced inhibition of ROI production). 3 receptor agonists on freshly isolated monocytes with those on cultured monocytes clearly showed that the inhibitory action was stronger in the latter. Whether this is mirrored by an upregulation of the two receptors at the protein level remains to be clarified; an upregulation of the A 2A receptor mRNA, however, could be observed.
The intracellular mechanisms involved in the inhibition of ROI production by adenosine have yet to be defined. A previous study by Broussas et al. (4) While Sullivan et al. (42) suggested an involvement of cAMP in A 2 receptor-mediated regulation of the oxidative burst in human neutrophils, other groups have questioned an enhancement of cAMP as an effector mechanism in these cells (6, 7) . Alternative signal transduction mechanisms such as activation of a serine/threonine protein phosphatase (39) or participation of inositol 1,4,5-phosphate (IP3) in A 2 receptor-mediated events (34) have been proposed.
In summary, our data show that differentiation of monocytes to macrophages is accompanied by the differential expression of adenosine receptor mRNA. This may provide potential means to regulate adenosine-mediated biological answers. Differences in the adenosine-mediated inhibition of the LPS-induced oxidative burst were seen between cultivated and freshly isolated monocytes. How far this effect, which we showed to be mediated by A 3 and A 2A receptors, relates to the expression of the corresponding adenosine receptor protein remains to be clarified.
